<DOC>
	<DOCNO>NCT01489306</DOCNO>
	<brief_summary>The purpose study assess tolerability safety range repeat inhaled dos MDT-637 . This include monitoring effect pulmonary function determination blood level MDT-637 follow inhalation .</brief_summary>
	<brief_title>A Trial Assess Safety , Tolerability Pharmacokinetics MDT-637 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Males and/or surgically sterile postmenopausal female ( confirm FSH test ) ; male must agree practice barrier contraception discharge study Willing give write informed consent 18 50 year age BMI 1930 kg/m2 Nonsmoker ( least 90 day prior screen ) willing abstain smoking course study Good general health determine medical history , physical examination , spirometry , ECG clinical laboratory test Willing abstain alcohol , caffeine , xanthinecontaining beverage 24 hour prior 24 hour dose Uncontrolled , clinically significant disease opinion Principal Investigator Sponsor ( MDTx ) would place subject risk study participation would confound assessment safety MDT637 Evidence current history respiratory disease ; instance asthma , emphysema , chronic bronchitis cystic fibrosis . Upper respiratory tract infection within 6 week Visit 1 Symptoms rhinitis ( stuffy nose , rhinorrhea , sneeze , nasal discharge ) within 2 week Visit 1 Current symptom cough , dyspnea , wheeze nocturnal awakening due respiratory symptom History significant nasal irritation nasal inhalation medication History malignancy History clinically significant alcohol drug abuse Positive drug screen drug abuse Positive test HIV , Hepatitis B Hepatitis C Allergy lactose , lactose intolerance Use prescription medication within 14 day Visit 2 overthecounter preparation , include dietary herbal supplement , within 5 day Visit 2 Positive urine pregnancy test Visit 1 Inability perform reproducible spirometry accordance American Thoracic Society/European Respiratory Society ( ATS/ERS ) guideline Abnormal QTc interval Visit 1 ( &gt; 450 msec male &gt; 470 msec female ) Significant blood donation ( test ) previous 8 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Respiratory Syncytial Virus Infection</keyword>
	<keyword>RSV</keyword>
</DOC>